Erratum to: Sorafenib versus capecitabine in the management of advanced hepatocellular carcinoma
- PMID: 26410783
- DOI: 10.1007/s12032-015-0688-6
Erratum to: Sorafenib versus capecitabine in the management of advanced hepatocellular carcinoma
Erratum for
-
Sorafenib versus capecitabine in the management of advanced hepatocellular carcinoma.Med Oncol. 2013;30(3):655. doi: 10.1007/s12032-013-0655-z. Epub 2013 Jul 4. Med Oncol. 2013. PMID: 23824645 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
